Skip to main content
Clinical Trials/NCT02550353
NCT02550353
Completed
Not Applicable

Comparison of Early Changes in Ocular Surface and Inflammatory Mediators Between Lenticule Extraction and Femtosecond Laser-assisted Laser in Situ Keratomileusis

Sun Yat-sen University1 site in 1 country75 target enrollmentSeptember 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Myopia
Sponsor
Sun Yat-sen University
Enrollment
75
Locations
1
Primary Endpoint
central corneal sensitivity
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The aim is to evaluate the short-term changes in ocular surface measures and tear inflammatory mediators after lenticule extraction (FLEx) and femtosecond laser-assisted laser in situ keratomileusis (FS-LASIK) procedures.

Detailed Description

Over the past few years, laser in situ keratomileusis with a femtosecond laser-created flap (FS-LASIK)has been a popular ophthalmic procedure for the correction of refractive error. This first all-in-one FS-laser system was designed to perform the refractive lenticule extraction (ReLEx) procedures, femtosecond lenticule extraction (FLEx).They have the same feature: corneal flap. Ocular surface disruption during corneal refractive surgery is commonly considered to be closely related to the development of dry eye. Multiple etiologies contribute to this ocular surface disruption, including the flap creation and stromal ablation involved in previous refractive surgery techniques. Corneal nerve damage has been considered the main cause of dry eye, due to disrupted afferent sensory nerves, reduced blink reflex, and increased tear evaporation leading to tear film instability. In addition, postoperative inflammatory mediator fluctuations are also a key factor related to ocular surface damage. Extensive research has described the effects of cytokines, chemokines and growth factors in modulating corneal wound healing, cell migration, and apoptosis on the ocular surface after refractive surgery. This prospective clinical study is going to assess the short-term changes in ocular surface measures and tear inflammatory mediators after lenticule extraction (FLEx) and femtosecond laser-assisted laser in situ keratomileusis (FS-LASIK) procedures.

Registry
clinicaltrials.gov
Start Date
September 2015
End Date
May 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Sun Yat-sen University
Responsible Party
Principal Investigator
Principal Investigator

Xingwu Zhong, MD PhD

Professor

Sun Yat-sen University

Eligibility Criteria

Inclusion Criteria

  • minimum age of 18 years(range from 18 year to 25 years)
  • corneal thickness 500 μm with calculated residual stromal bed after treatment greater than 300 μm
  • preoperative spherical equivalent refraction between- 2.00 diopter (D) and -6.50 D.preoperative cylindrical equivalent refraction between -0.25 D and -1.50 D.
  • preoperative corneal curvature from 41.0 D to 46.0 D with a regular topographic pattern monocular best corrected visual acuity of 20/20 or better and stable refractive error (less than 0.5 D change) for 24 months before surgery。

Exclusion Criteria

  • systemic disease that contraindicated the surgery (such as diabetes, glaucoma and systemic collagen vascular disease)
  • corneal abnormality or disease.
  • a history of tear supplement usage or contact lens wear during the past year.

Outcomes

Primary Outcomes

central corneal sensitivity

Time Frame: up to 1month after surgery

tear meniscus height

Time Frame: up to 1month after surgery

Schirmer I test

Time Frame: up to 1month after surgery

corneal fluorescein staining

Time Frame: up to 1month after surgery

noninvasive tear breakup time

Time Frame: up to 1month after surgery

ocular surface disease index

Time Frame: up to 1month after surgery

Interleukin-1α

Time Frame: up to 1month after surgery

tumor necrosis factor-α

Time Frame: up to 1month after surgery

nerve growth factor

Time Frame: up to 1month after surgery

interferon-γ

Time Frame: up to 1month after surgery

transforming growth factor-β1

Time Frame: up to 1month after surgery

matrix metalloproteinase-9

Time Frame: up to 1month after surgery

Secondary Outcomes

  • Correlation Between Inflammatory Mediators and Ocular Surface Changes(up to 1month after surgery)

Study Sites (1)

Loading locations...

Similar Trials